An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0.398. It has been cited 10 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.0381
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
Japan Agency for Medical Research and Development
Grant: JP22wm0125002
Japan Agency for Medical Research and Development
Grant: JP223fa627001
Welch Foundation
Grant: A-0015
National Cancer Institute
Grant: JP21nf0101632
National Cancer Institute
Grant: JP21fk0108552
National Cancer Institute
Grant: JP21fk0108615
National Cancer Institute
Grant: 5P30CA016080-42